Synthesis method of naphthofuran derivative, naphthofuran derivative and application
A synthetic method and derivative technology, applied in drug combination, antineoplastic drugs, organic chemistry, etc., can solve the problems of poor functional group tolerance, high cost of raw materials, cumbersome post-processing, etc., and achieve good yield, simple raw materials, and post-processing simple effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0050] Such as figure 1 As shown, the embodiment of the present invention also proposes a method for synthesizing the naphthofuran derivative represented by formula (I), including:
[0051] In S101, the furan aryl propargyl alcohol protected by Boc reacts with the aryl boronic acid under suitable conditions of transition metal, additives, solvent, and reaction temperature.
[0052] S102, the naphthofuran derivative represented by formula (I) is obtained.
[0053] In step S10, o-furan aryl propargyl alcohol derivatives and aryl boronic acid are used as raw materials.
[0054] The reaction process is shown in formula (II):
[0055]
[0056] Among them, R 1 , R 2 Respectively selected from phenyl, naphthyl, aryl substituted by electron donating group, aryl substituted by electron withdrawing group, alkyl, hydrogen; R 3 It is halogen, methoxy, hydrogen.
[0057] In the embodiment of the present invention, R 1 , R 2 Respectively selected from phenyl, naphthyl, p-methylphenyl, p-methoxyphenyl...
Example Embodiment
[0074] Example 1: Synthesis of IA
[0075]
[0076] O-furan aryl propargyl alcohol derivatives, aryl boronic acid, catalysts, additives, and reaction solvents are Boc protected o-furan phenyl phenyl propargyl alcohol, phenylboronic acid, tetrakistriphenylphosphine palladium, cesium carbonate, 1, 4-Dioxane. The dosages were 0.3 mmol of Boc-protected o-furanphenyl phenyl propargyl alcohol, 0.6 mmol of phenylboronic acid, 0.006 mmol of palladium tetrakistriphenylphosphine, 0.6 mmol of cesium carbonate, and 3 mL of 1,4-dioxane. The reaction was carried out at 100°C for 2 hours, then cooled to room temperature, concentrated, and column chromatography was used to obtain the target product formula (IA) as a pale yellow solid with an isolated yield of 78%. Mp 194-196°C.
[0077] NMR data: 1 H NMR(CDCl 3 , 400MHz): δ 5.96 (s, 1H), 5.60 (d, J = 1.6 Hz, 1H), 7.17 (s, 1H), 7.25 (d, J = 6.0 Hz, 4H), 7.30 (t, J = 6.0Hz, 2H), 7.36 (t, J = 5.6 Hz, 4H), 7.47 (t, J = 5.6 Hz, 1H), 7.59 (t, J = 5.6...
Example Embodiment
[0079] Example 2: Synthesis of IB
[0080]
[0081] Chlorine-substituted o-furan aryl propargyl alcohol derivatives, aryl boronic acid, catalysts, additives, and reaction solvents are Boc-protected o-furan phenyl phenyl propargyl alcohol, phenylboronic acid, tetrakistriphenylphosphine palladium, cesium carbonate, 1,4-Dioxane. The dosages are respectively 0.3 mmol of Boc-protected chlorine-substituted o-furan phenyl phenyl propargyl alcohol, 0.6 mmol of phenylboronic acid, 0.006 mmol of tetratriphenylphosphine palladium, 0.6 mmol of cesium carbonate, and 3 mL of 1,4-dioxane. The reaction was carried out at 100°C for 2 hours, then cooled to room temperature, concentrated, and column chromatographed to obtain the target product formula (IB) as a pale yellow solid with an isolated yield of 72%. Mp 171-173°C.
[0082] NMR data: 1 H NMR(CDCl 3 ,400MHz): δ5.88(s,1H), 6.53(s,1H), 7.07(s,1H), 7.17-7.34(m,11H), 7.60-7.67(m,2H), 8.23(s,1H) ). 13 C NMR(CDCl 3 ,100MHz): δ54.75,107.11,119.23,...
PUM
Property | Measurement | Unit |
---|---|---|
Separation yield | aaaaa | aaaaa |
Separation yield | aaaaa | aaaaa |
Separation yield | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap